Logo image of NNE

NANO NUCLEAR ENERGY INC (NNE) Stock Fundamental Analysis

NASDAQ:NNE - Nasdaq - US63010H1086 - Common Stock - Currency: USD

39.5  +3.91 (+10.99%)

Premarket: 38.85 -0.65 (-1.65%)

Fundamental Rating

2

Overall NNE gets a fundamental rating of 2 out of 10. We evaluated NNE against 94 industry peers in the Electrical Equipment industry. NNE has a great financial health rating, but its profitability evaluates not so good. NNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NNE had negative earnings in the past year.
NNE had a negative operating cash flow in the past year.
NNE Yearly Net Income VS EBIT VS OCF VS FCFNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

NNE has a worse Return On Assets (-89.99%) than 84.04% of its industry peers.
The Return On Equity of NNE (-99.92%) is worse than 60.64% of its industry peers.
Industry RankSector Rank
ROA -89.99%
ROE -99.92%
ROIC N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNE Yearly ROA, ROE, ROICNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

NNE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNE Yearly Profit, Operating, Gross MarginsNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for NNE has been increased compared to 1 year ago.
NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NNE Yearly Shares OutstandingNNE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
NNE Yearly Total Debt VS Total AssetsNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M

2.2 Solvency

NNE has an Altman-Z score of 251.81. This indicates that NNE is financially healthy and has little risk of bankruptcy at the moment.
NNE's Altman-Z score of 251.81 is amongst the best of the industry. NNE outperforms 98.94% of its industry peers.
NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 251.81
ROIC/WACCN/A
WACCN/A
NNE Yearly LT Debt VS Equity VS FCFNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 15.96 indicates that NNE has no problem at all paying its short term obligations.
NNE's Current ratio of 15.96 is amongst the best of the industry. NNE outperforms 97.87% of its industry peers.
A Quick Ratio of 15.96 indicates that NNE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 15.96, NNE belongs to the best of the industry, outperforming 97.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.96
Quick Ratio 15.96
NNE Yearly Current Assets VS Current LiabilitesNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

NNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.83%.
EPS 1Y (TTM)-173.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-717.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -35.10% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-50%
EPS Next 2Y-32.29%
EPS Next 3Y-35.1%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNE Yearly Revenue VS EstimatesNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 10M 20M 30M
NNE Yearly EPS VS EstimatesNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NNE. In the last year negative earnings were reported.
Also next year NNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNE Price Earnings VS Forward Price EarningsNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNE Per share dataNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A cheap valuation may be justified as NNE's earnings are expected to decrease with -35.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.29%
EPS Next 3Y-35.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANO NUCLEAR ENERGY INC

NASDAQ:NNE (6/24/2025, 8:00:02 PM)

Premarket: 38.85 -0.65 (-1.65%)

39.5

+3.91 (+10.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-13 2025-08-13
Inst Owners22.01%
Inst Owner Change17.69%
Ins Owners1.61%
Ins Owner Change0%
Market Cap1.48B
Analysts80
Price Target48.45 (22.66%)
Short Float %24.4%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-243.78%
Min EPS beat(2)-527.06%
Max EPS beat(2)39.49%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)32.26%
EPS NY rev (1m)-55.29%
EPS NY rev (3m)-10.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-91.67%
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-35.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 46.86
P/tB 46.86
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -89.99%
ROE -99.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.96
Quick Ratio 15.96
Altman-Z 251.81
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-717.64%
EPS Next Y-50%
EPS Next 2Y-32.29%
EPS Next 3Y-35.1%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-262.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.74%
EBIT Next 3Y-38.95%
EBIT Next 5YN/A
FCF growth 1Y-162.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.85%
OCF growth 3YN/A
OCF growth 5YN/A